Jiali Wu,1 Xiaodong Sun1–31Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Shanghai Key Laboratory of Fundus Disease, Shanghai, People’s Republic of China; 3Shanghai sophie allport bee curtains Engineering Center for Visual Science and Photomedicine, Shanghai, People’s Republic of ChinaAbstract: Age-related macular degeneration (AMD) is directly attributable to vision loss, posing significant pressure on public health.AMD is recognized to be a multi-factorial disease and among them, complement system is under heated discussion in recent years.In this review, socialstudiesscholar.com we start with an overview of complement pathways involved in AMD and their therapies correspondingly.Finally, we discuss the development of the therapeutics existed now.
Also, we enclose a list of drugs undergoing clinical trials.Keywords: age-related macular degeneration, inflammation, complement system, immunotherapy.